Emerging risks | Growth Opportunities | APAC Insurance

Thursday, November 5, 2026

Life, Life and Health, News, Results, Strategy

Sun Life’s Asia new business CSM decline extends into Q3 despite 9% sales growth

Weaker China sales and intensifying Hong Kong competition continued to weigh on new business profitability.

By

Reih Angeles

November 5, 2026

•

3 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

Hong Kong competition erodes Sun Life's Asia new business CSM despite 19% sales rise August 7 2026
Manulife's Asia APE sales decline, new business growth stalls in Q3 as core earnings rise 17% November 5 2026
Hanwha Life new business CSM rises 40.5% to record US$913m in H1 August 14 2026
Lloyd's extends strong underwriting streak into 2025 – AM Best September 21 2026
Fitch removes TransGlobe Life from Rating Watch Negative following CSM improvement November 4 2026
Lonpac improves underwriting performance despite parent LPI Capital's earnings decline in Q3 October 27 2026